Decentralized Trials: How to Develop a Flexible Supply Chain Strategy

Nina Vas, Vice President, Clinical Distribution, Cell & Gene Supply Chain, Marken

Nina Vas is Marken’s Vice President, Clinical Distribution, Cell & Gene Supply Chain and focuses on leading Marken’s global GMP depot network as well as its fast-growing cell and gene division. She oversees their global network of liquid nitrogen storage facilities and Marken’s designated Centers of Excellence for cell and gene therapy logistics across the U.S., Europe, and Asia. She brings financial, operational, quality and process improvement experience to managing the performance of the full supply chain and supporting the execution of distribution for clinical trials to global destinations. Her background includes importing and exporting of drug product (from API to finished goods and ancillaries) with Clinical Research Organizations, Pharmaceutical Importers, owned facilities and third‐party depots. Nina previously served as Managing Director for one of the largest CMOs in the industry.

Gaurang Majmudar, Senior Director, Global Patient Centric Services, Marken

As senior director, Global Patient Centric Services at Marken, Gaurang is responsible for overseeing the expansion of patient centric services in the EMEA and APAC regions and the development of new service offerings for our clients to further expand and streamline the clinical trial experience for patients and sponsors.

Gaurang offers a wealth of experience from the pharmaceutical, distribution, and home healthcare industries. He has held senior marketing and commercial roles within pharmaceutical companies, where he was responsible for product development and launches within specialty medicines and orphan diseases sectors.

Prior to Marken, Gaurang worked with Walgreens Boots Alliance (WBA), where he was responsible for the development of their patient services offering across Europe and other global locations. He led the launch of the WBA Alcura business across six markets in the EU including patient services and clinical trials support. In other roles, he has advised and led global pharma teams focused on patient centric services and implemented patient support programs (PSPs) for specialty medicines.